According to our (Global Info Research) latest study, the global Stereotactic Radiosurgery (SRS) market size was valued at US$ 3629 million in 2025 and is forecast to a readjusted size of US$ 6032 million by 2032 with a CAGR of 7.4% during review period.
Stereotactic Radiosurgery (SRS) is a non-incisional, high-precision radiation therapy technique that uses a stereotactic reference system and image guidance to deliver a highly focused, ablative dose to a clearly defined target—classically in the head—with about millimeter-level targeting accuracy. In clinical practice, “SRS” is commonly used for single-fraction treatment, while “fractionated cranial stereotactic radiosurgery”may be delivered in 2–5 fractions under the same stereotactic accuracy requirements.
Upstream components of an SRS “system” include: (1) the radiation delivery platform—gamma-ray devices (e.g., multi-source Co-60), medical linear accelerators (photon-based), or particle beam accelerators; (2) beam-shaping/collimation hardware (cones, MLC/micro-MLC, sector/secondary collimation); (3) patient immobilization and stereotactic localization hardware (frames, masks, fiducials); (4) imaging and image guidance (CT/MRI/angiography; stereoscopic X-ray, cone-beam CT, skull/fiducial tracking); and (5) treatment planning software plus dosimetry/QA tools required for commissioning and ongoing verification.
Downstream, SRS is delivered mainly in radiation oncology and neurosurgery programs (often multidisciplinary) for selected intracranial targets and, in some practice settings, spine targets when stereotactic accuracy can be maintained. Typical clinical workflow links high-resolution imaging and contouring, stereotactic setup/verification, plan optimization, and carefully protocolized QA, with the goal of maximizing target ablation while minimizing dose to adjacent critical structures.
In 2025, global sales of Stereotactic Radiosurgery (SRS) reached approximately 2,528 units, with an average global market price of around US$ 1.4 million/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 30% to 45%.
Stereotactic radiosurgery is valued for high-dose, hypofractionated delivery with sub-millimeter targeting. It is increasingly moving from a “premium add-on” to a standard capability in radiation oncology centers, especially for brain metastases, benign intracranial tumors, vascular malformations, and selected extracranial oligometastatic cases. As survivorship improves and imaging-driven detection expands, hospitals are more likely to invest not only in SRS-capable platforms, but also in tightly integrated planning, image guidance, and quality management workflows to improve throughput and reduce inter-operator variability.
Demand is propelled by the preference for non-invasive care and the operational advantages of shorter treatment courses. On the supply side, advances in IGRT, motion management, beam shaping, and dose calculation—together with automation such as auto-contouring and plan optimization—are lowering the expertise barrier and making high-precision delivery more scalable. However, adoption can still be constrained by capital budgeting cycles, bunker and radiation shielding requirements, regulatory compliance, and the time needed to build and retain experienced physics and therapy teams.
Competition is shifting from standalone hardware differentiation toward software- and service-driven end-to-end solutions: adaptive workflows, online/remote QA, connectivity and data integration, and standardized deployment across multi-site networks. Vendors that can package clinical consistency, operational efficiency, and long-term service assurance are better positioned to win both new installations and installed-base upgrades.
This report is a detailed and comprehensive analysis for global Stereotactic Radiosurgery (SRS) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Stereotactic Radiosurgery (SRS) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Stereotactic Radiosurgery (SRS) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Stereotactic Radiosurgery (SRS) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Stereotactic Radiosurgery (SRS) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Stereotactic Radiosurgery (SRS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Stereotactic Radiosurgery (SRS) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Elekta, Varian, Accuray, American Radiosurgery, ZAP Surgical Systems, Akesis, China Isotope & Radiation Corporation (CIRC), Masep Medical, Our United, Shanghai United Imaging Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Stereotactic Radiosurgery (SRS) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gamma Knife
Linear Accelerator (Linac)
Proton Beam Therapy
Market segment by Fractionation Scheme
Single-fraction SRS
Hypofractionated Cranial SRS
Market segment by Image Guidance
Stereoscopic X-ray Guidance
Cone-beam CT (CBCT) Guidance
Fiducial-based Image Guidance
Market segment by Application
Brain Stereotactic Radiosurgery
Stereotactic Body Radiation Therapy (SBRT)
Major players covered
Elekta
Varian
Accuray
American Radiosurgery
ZAP Surgical Systems
Akesis
China Isotope & Radiation Corporation (CIRC)
Masep Medical
Our United
Shanghai United Imaging Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Stereotactic Radiosurgery (SRS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Stereotactic Radiosurgery (SRS), with price, sales quantity, revenue, and global market share of Stereotactic Radiosurgery (SRS) from 2021 to 2026.
Chapter 3, the Stereotactic Radiosurgery (SRS) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Stereotactic Radiosurgery (SRS) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Stereotactic Radiosurgery (SRS) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Stereotactic Radiosurgery (SRS).
Chapter 14 and 15, to describe Stereotactic Radiosurgery (SRS) sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Stereotactic Radiosurgery (SRS). Industry analysis & Market Report on Stereotactic Radiosurgery (SRS) is a syndicated market report, published as Global Stereotactic Radiosurgery (SRS) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Stereotactic Radiosurgery (SRS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.